This is the authors' abstract. We don't add key points for this paper.
The transgenic mouse models expressing beta s-globin genes do not fully exhibit the sickling phenotype, primarily as a result of the inhibition of beta s-chain-dependent polymerization by the mouse alpha-chains. The mouse alpha-chain differs from the human alpha-chain at 19 sequence locations. Of these, only alpha 78 and alpha 116 are the known hemoglobin (Hb) S polymer contact sites. To define whether the inhibition of polymerization by the mouse alpha-chain is solely a consequence of the differences at these two sites or additional sites of sequence differences are also involved, we have constructed chimeric alpha-chains by employing the alpha-globin semisynthetic reaction (Sahni, G., Cho, Y. J., Iyer, K. S., Khan, S. A., Seetharam, R., and Acharya, A. S. (1989) Biochemistry 28, 5456-5461). Mouse alpha 1-30 was spliced with human alpha 31-141 using endoproteinase Glu-C to generate a chimeric alpha-globin (alpha MH) containing eight of the 19 sequence differences of mouse alpha-globin. Similarly, human alpha 1-30 was spliced with mouse alpha 31-141 to generate another chimeric alpha-globin (alpha HM) containing 11 sequence differences. The respective chimeric globins were purified, reconstituted with heme and beta s-chain into tetrameric hemoglobin, and the tetramers were purified by ion-exchange chromatography. The inhibitory potential of the chimeric alpha MH-chain on the polymerization is 10-fold lower than that of the mouse alpha-chain. The absence of the alpha 31-141 region of the mouse alpha-chain relieves only a portion of the inhibition. The inhibitory potential of alpha MH contributed by the mouse alpha 1-30 segment is significant although none of the sequence differences in this segment are located at any of the implicated polymer contact sites. The chimeric alpha HM-chain also inhibits the polymerization, but the extent of inhibition is again lower (4-fold) than that of the full-length mouse alpha-chain. The results demonstrate that the inhibitory potential of mouse alpha-chains involves the sequence differences from both the alpha 1-30 and alpha 31-141 regions. Besides, since the sum of the inhibitory potential of either of these chimeric alpha-chains is lower than that of the intact mouse alpha-chains, we speculate that conformational changes that require the copresence of sequence differences in both portions of the mouse alpha-chain also contribute to the inhibitory propensity of the mouse alpha-chain.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Roy et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: